Our Strategy
BBS Pharmaceuticals

The BBS Pharmaceuticals Strategy

The BBS board has developed a sound business growth strategy under an operational framework that suits the growing market and adjusting to the challenges that COVID19 has presented to the global economy.

The BBS Board has vast contiguous land holdings. Its current facilities being built in Regional South Australia will be operational by mid 2021 and will over the next decade become the largest of their type in Australia.


Our Company has adopted a strategy of minimising all types of risks while delivering the highest quality to our clients.


We have operations both in Australia and offshore through a subsidiary company to ensure that product deadlines are met whilst ensuring the highest quality product that is both GACP and EuGMP compliant.


This is delivering regular and healthy cashflows for the company that is now a true multinational.

168+

People

6 leading

Universities

12

Countries

15

Collaborations